Ian Michael Estepan - Sep 3, 2025 Form 4 Insider Report for Sarepta Therapeutics, Inc. (SRPT)

Role
Chief Operating Officer
Signature
/s/ Cristin Rothfuss, as Attorney-in-Fact for Ian Michael Estepan
Stock symbol
SRPT
Transactions as of
Sep 3, 2025
Transactions value $
$0
Form type
4
Date filed
9/5/2025, 09:30 PM
Previous filing
Aug 6, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Estepan Ian Michael Chief Operating Officer 215 FIRST STREET, SUITE 415, CAMBRIDGE /s/ Cristin Rothfuss, as Attorney-in-Fact for Ian Michael Estepan 2025-09-05 0001836254

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SRPT Common Stock Award $0 +93.9K +149.93% $0.00 156K Sep 3, 2025 Direct F1
transaction SRPT Common Stock Award $0 +50K +31.95% $0.00 206K Sep 3, 2025 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person was granted restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock. 50% of the RSUs will vest on September 3, 2026, and the remaining 50% will vest on September 3, 2027, subject to the Reporting Person's continued service to the Company.
F2 The Reporting Person was granted restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock. 100% of the RSUs will vest on September 3, 2028, subject to the Reporting Person's continued service to the Company and only if certain performance criteria has been deemed achieved by the Compensation Committee of the Board.